Taurocholate prevents TNF-α-induced bile duct damage of bile duct ligated (BDL) rats by Ca2+- and PKC-dependent mediated mechanisms

被引:0
|
作者
Taffetani, S
Patel, T
Ueno, Y
Venter, J
Francis, H
Baumann, B
Glaser, S
Marienfeld, C
Phinizy, JL
Marzioni, M
Benedetti, A
Alpini, G
机构
关键词
D O I
10.1016/S0016-5085(03)83683-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A729 / A729
页数:1
相关论文
共 50 条
  • [41] Ablation of the D2 dopaminergic innervation by intraportal injection of 6-hydroxidopamine (6-OHDA) reduces cholangiocyte proliferative and secretory activity in bile duct ligated (BDL) rats.
    Glaser, S
    Lesage, G
    Alvaro, D
    Chowdury, U
    Kanno, N
    Francis, H
    Eisel, W
    Alpini, G
    HEPATOLOGY, 1999, 30 (04) : 432A - 432A
  • [42] The α-2 adrenergic receptor agonist, UK14,304, inhibits secretin-stimulated ductal secretion of bile duct ligated (BDL) rats by activation of the G-protein GαI.
    Francis, H
    Glaser, S
    Alvaro, D
    Taffetani, S
    Marucci, L
    Benedetti, A
    Ueno, Y
    Marzioni, M
    LeSage, G
    Venter, J
    Baumann, B
    Phinizy, JL
    Alpini, G
    HEPATOLOGY, 2003, 38 (04) : 678A - 679A
  • [43] INTERFERON-ALPHA(2B) PREVENTS LIVER COLLAGEN DEPOSITION AND DAMAGE-INDUCED BY PROLONGED BILE-DUCT LIGATION IN THE RAT
    MURIEL, P
    GONZALEZ, MP
    HEPATOLOGY, 1994, 20 (04) : A378 - A378
  • [44] Effects of S-adenosyl-L-methionine and interferon-α2b on liver damage induced by bile duct ligation in rats
    Muriel, P
    Castro, V
    JOURNAL OF APPLIED TOXICOLOGY, 1998, 18 (02) : 143 - 147
  • [45] The alpha-2 adrenergic receptor agonist, UK14,304, inhibits secretin-stimulated ductal secretion of bile duct ligated (BDL) rats by a decrease in camp levels and PKA activity.
    Alvaro, D
    Francis, H
    Glaser, S
    Marucci, L
    Benedetti, A
    Ueno, Y
    Marzioni, M
    Phinizy, JL
    Rashid, S
    Alpini, G
    HEPATOLOGY, 2002, 36 (04) : 462A - 462A
  • [46] Activation of serotonin receptor 5-HT1A and 5-HT1B subtypes inhibits cholangiocyte proliferation and secretion of bile duct ligated (BDL) rats in a CAMP/PKA/SRC/ERK 1/2 dependent manner.
    Marzioni, M
    Marucci, L
    Glaser, S
    Benedetti, A
    Francis, H
    Baumann, B
    Venter, J
    Mauldin, J
    Phinizy, JL
    Alpini, G
    HEPATOLOGY, 2002, 36 (04) : 344A - 344A
  • [47] The specific H3/H4 histamine receptor (HR) agonist, RAMH, inhibits cholangiocyte proliferation in bile duct ligated (BDL) rats by negative regulation of the camp-dependent PKA/Erk1/2 pathway.
    Francis, H
    Glaser, S
    Venter, J
    Taffetani, S
    Reichenbaeh, R
    Fava, G
    Marucci, L
    Benedetti, A
    Alvaro, D
    Summers, R
    Wyndham, M
    Vaculin, S
    Alpini, G
    HEPATOLOGY, 2004, 40 (04) : 367A - 367A
  • [48] Effects of S-adenosyl-L-methionine and interferon-alpha(2b) on liver damage induced by bile duct ligation in rats.
    Muriel, P
    Castro, V
    HEPATOLOGY, 1997, 26 (04) : 1761 - 1761
  • [49] Substance P stimulates biliary growth during cholestasis induced by extrahepatic bile duct obstruction (BDL) via activation of ERK1/2/p38/CREB signaling mechanisms
    Glaser, Shannon
    Katki, Khurshed
    DeMorrow, Sharon
    Supowit, Scott
    Gaudio, Eugenio
    Ueno, Yoshiyuki
    Venter, Julie
    Vaculin, Bradley
    Francis, Heather
    Chiasson, Valorie
    DiPette, Donald
    Alpini, Gianfranco
    HEPATOLOGY, 2006, 44 (04) : 603A - 604A
  • [50] The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway
    Yu, Dong-ke
    Zhang, Cai-xia
    Zhao, Shuang-shuang
    Zhang, Sheng-hua
    Zhang, Hao
    Cai, Shi-ying
    Shao, Rong-guang
    He, Hong-wei
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (04) : 473 - 482